Study Finds GLP-1 Receptor Agonists May Reduce Cancer Risk in Adults with Obesity
GLP-1 receptor agonists like semaglutide show promise in reducing obesity-related cancer risks, while highlighting the need for ongoing safety monitoring.
https://prabadinews.com/